BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 157758)

  • 21. [Vaccination against rubella].
    Böttiger M
    Lakartidningen; 1979 Oct; 76(41):3516-8. PubMed ID: 522538
    [No Abstract]   [Full Text] [Related]  

  • 22. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
    Okafuji T; Okafuji T; Nakayama T
    Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laboratory diagnosis of rubella virus infections.
    Iwakata S; Rhodes AH; Labzoffsky NA
    Can Med Assoc J; 1973 Apr; 108(7):894-5 passim. PubMed ID: 4581796
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rubella immunity in Alsace. A study of 1026 serums by hemagglutination inhibition reaction].
    Wurtz R; Lab M; Kirn A
    Pathol Biol (Paris); 1970 Apr; 18(7):387-91. PubMed ID: 4911089
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New prospects in vaccination against rubella].
    Cocchi P; Ulivelli A
    Recenti Prog Med; 1975 May; 58(5):535-59. PubMed ID: 1094515
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytostatic therapy reduces the immune defense. Children treated for leukemia have impaired immunity against measles and rubella].
    Nilsson A; Nordin M; De Milito A; Grillner L; Chiodi F; Björk O
    Lakartidningen; 2000 Nov; 97(45):5116-8. PubMed ID: 11116890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Distribution of hemagglutination-inhibition antibodies against rubella virus in a sample of the female population in Emilia-Romagna (author's transl)].
    Mazzaracchio R; Re MC; Nanetti A
    Ann Sclavo; 1980; 22(2):136-40. PubMed ID: 7469535
    [No Abstract]   [Full Text] [Related]  

  • 29. Rubella immunity measured by hemagglutination inhibition and enzyme-linked immunosorbent assay.
    Hornstein L; Swartz TA; Heimann M
    Isr J Med Sci; 1985 Aug; 21(8):666-9. PubMed ID: 4044233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Test of anti-rubella vaccination with live and attenuated virus (Cendehill strain)].
    Leogrande G; Barnaba L; Iandolo E; Iatta E
    Minerva Med; 1970 Apr; 61(30 Suppl):1595-8. PubMed ID: 4378365
    [No Abstract]   [Full Text] [Related]  

  • 31. Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated and naturally immune groups.
    Baba K; Yabuuchi H; Okuni H; Harima R; Minekawa Y; Taniuchi M; Otsuka T; Takahashi M; Okuno Y
    Biken J; 1978 Mar; 21(1):25-31. PubMed ID: 666723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Necessity and strategy of rubella vaccination].
    Sandow D; Gerike E; Rasch G; Rosmus K
    Z Arztl Fortbild (Jena); 1990; 84(8):373-5. PubMed ID: 2378119
    [No Abstract]   [Full Text] [Related]  

  • 33. The immunoglobulin response to reimmunization with rubella vaccine.
    Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
    J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    Kańtoch M; Rudnicka H; Imbs D
    Przegl Epidemiol; 1985; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunization of man against rubella. Discussion on sessions 3 and IV.
    Am J Dis Child; 1969 Aug; 118(2):307-21. PubMed ID: 4978511
    [No Abstract]   [Full Text] [Related]  

  • 37. [Distribution of anti-rubella virus antibodies in a female population sample of the community of Perugia and serological results of an anti-rubella vaccination experiment].
    Iorio AM; Rivosecchi P; Fanelli M; Pitzurra M
    Boll Ist Sieroter Milan; 1972; 51(5):405-9. PubMed ID: 4656955
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience with vaccination with attenuated rubella vaccine (strain HPV-77 adapted to duck cells, 5th passage)].
    Rocchi G; Salvadori A
    Nuovi Ann Ig Microbiol; 1970; 21(4):336-40. PubMed ID: 5518412
    [No Abstract]   [Full Text] [Related]  

  • 39. [Controlled rubella vaccination at the Stuttgart Public Health Center].
    Fischer D; Beyer von Voigt T; Bontemps M
    Offentl Gesundheitswes; 1991 Apr; 53(4):161-2. PubMed ID: 1830944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Susceptibility of pregnant women to rubella and the implications of immunization programs].
    Villalbí JR; Graells C; Marín T
    An Esp Pediatr; 1988 Feb; 28(2):137-40. PubMed ID: 3355032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.